Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.
about
Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humansEnhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow.Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitorsCirculating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injuryPoly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine modelCell-based therapies for diabetic retinopathy.Stem cell therapies in the treatment of diabetic retinopathy and keratopathy.Advances in bone marrow stem cell therapy for retinal dysfunction.Good news-bad news: the Yin and Yang of immune privilege in the eye.Editorial: Cell-Based Therapies for Diabetic Microvascular Complications.Wound Healing Angiogenesis: Innovations and Challenges in Acute and Chronic Wound Healing.Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes.
P2860
Q34355975-9975FBFC-F2DC-46F0-A0D1-44AAF8FD21F5Q35041129-562D19F4-7999-4CA0-8E14-9586D7A3EA0DQ35142725-151F37B9-216E-4A21-AABC-D6020BB81602Q35221390-503666CC-AA93-449D-A0C6-1E834FA3461DQ36477259-8100A73F-7DBF-47E7-8640-D8F66E0F9E3DQ36720543-E8F35C6E-4CD3-40BD-B347-FF8E739069B4Q36802005-27297C21-1A0C-41EC-86B7-6249F9B819E7Q37172217-2559F038-4F5D-4709-A1C8-D85CAE1712A5Q37172543-4320340D-579F-42CD-8504-B744C1E8F628Q37879584-A18E0D0D-5B1F-4275-9AC3-17D500EEBAF2Q38603660-C0918F6B-3A68-44F2-A6F2-9531DEBA0C16Q38804673-71899BD6-947B-47B4-84CC-164A295368C5Q41780299-79CFAB4B-E1C8-4622-B2F3-4C3EF37A7971Q42092958-A63C0EB6-983E-455B-BB9B-39F32B63D271Q43183138-8DB04A72-03E3-4659-842F-018D938084E5Q51026956-2ABE6E17-D261-4AC0-9A8B-66F8C22F1AA9
P2860
Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transient inhibition of transf ...... vascular reparative functions.
@ast
Transient inhibition of transf ...... vascular reparative functions.
@en
Transient inhibition of transf ...... vascular reparative functions.
@nl
type
label
Transient inhibition of transf ...... vascular reparative functions.
@ast
Transient inhibition of transf ...... vascular reparative functions.
@en
Transient inhibition of transf ...... vascular reparative functions.
@nl
prefLabel
Transient inhibition of transf ...... vascular reparative functions.
@ast
Transient inhibition of transf ...... vascular reparative functions.
@en
Transient inhibition of transf ...... vascular reparative functions.
@nl
P2093
P2860
P356
P1433
P1476
Transient inhibition of transf ...... vascular reparative functions.
@en
P2093
Ashay D Bhatwadekar
Carl J Pepine
David Kent
E P Guerin
Frank W Ruscetti
Laurence Kennedy
M Cecilia Lansang
Maria B Grant
Paul J Higgins
Sergio Caballero
P2860
P304
P356
10.2337/DB10-0287
P407
P577
2010-05-11T00:00:00Z